Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5164350 | 1.00 | ALOX15 (0.51) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL22281512 | 0.79 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL19538265 | 0.75 | ALOX15 (0.43) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL19538321 | 0.72 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL22052557 | 0.72 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL9955224 | 0.70 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL22281629 | 0.70 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17627631 | 0.68 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL1005543 | 0.68 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17634351 | 0.68 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514844-B1 | Cannabinoid compositions and dosage forms | Lock Box LLC (US) | 2026-01-06 | — | — | US | claimed |
| US-12029722-B2 | Dosage delivery film | Spartak LLC (US) | 2024-07-09 | — | — | US | claimed |
| US-11384306-B2 | Traction fluids | THE LUBRIZOL CORPORATION (US) | 2022-07-12 | — | — | US | claimed |
| US-20260009054-A1 | METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL AND RELATED SERRULATANE-TYPE DITERPENES | UNIV MICHIGAN STATE (US) | 2026-01-08 | — | — | US | disclosed |
| US-12514844-B1 | Cannabinoid compositions and dosage forms | Lock Box LLC (US) | 2026-01-06 | — | — | US | disclosed |
| WO-2025233712-A1 | SYNTHESIS METHOD OF CEDRENE CIS-DIOL | POLITECNICO DI MILANO (IT) | 2025-11-13 | — | — | WO | disclosed |
| WO-2025231524-A1 | CANNABINOID COMPOSITIONS | Heyday RX Pty Ltd (AU) | 2025-11-13 | — | — | WO | disclosed |
| US-20250325566-A1 | COMPOSITION COMPRISING DELTA-9-TETRAHYDROCANNABINOL AND TERPENES | Vertanical GmbH (DE) | 2025-10-23 | — | — | US | disclosed |
| EP-4619459-A1 | MODIFIED PU FOAM | Wenatex Forschung - Entwicklung - Produktion GmbH (AT) | 2025-09-24 | — | — | EP | disclosed |
| US-12378579-B2 | Method to produce the anti-microbial diterpenoid leubethanol and related serrulatane-type diterpenes | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2025-08-05 | — | — | US | disclosed |
| CN-120423931-A | Celastracene diterpenoid compound and preparation method and application thereof | 云南省烟草农业科学研究院 | 2025-08-05 | — | — | CN | disclosed |
| WO-2008027515-A2 | PHOSPHORUS-CONTAINING STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027511-A1 | EPOXIDE AND FLUORINATED EPOXIDE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027595-A1 | ALKYL SILANE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027594-A2 | PHENOL STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008027596-A2 | BENZOPHENONE DERIVATIVE STABILIZERS FOR FLUOROOLEFINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2007126760-A2 | COMPOSITIONS COMPRISING IODOTRIFLUOROMETHANE AND STABILIZERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-11-08 | — | — | WO | disclosed |
| WO-2007079133-A2 | SYSTEM AND METHOD FOR RECYCLING WASTE INTO ENERGY | NATURAL RESOURCE RECOVERY, INC. (US) | 2007-07-12 | — | — | WO | disclosed |
| US-20070108403-A1 | refrigerants as heat exchanger; comprising 1,1,1,4,4,5,5,5-octafluoro-2-pentene mixture | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-17 | — | — | US | disclosed |
| WO-2007053697-A2 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009054-A1 | METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL AND RELATED SERRULATANE-TYPE DITERPENES | CYP51A1, LSS, FNTB | ALOX15 246/4885ALDH1A1 1700/4885LMNA 1255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.